000 01133 a2200301 4500
005 20250516113539.0
264 0 _c20121211
008 201212s 0 0 eng d
022 _a1474-1784
024 7 _a10.1038/nrd3794
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiossec, Pierre
245 0 0 _aTargeting IL-17 and TH17 cells in chronic inflammation.
_h[electronic resource]
260 _bNature reviews. Drug discovery
_cOct 2012
300 _a763-76 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aChronic Disease
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aInterleukin-17
_xantagonists & inhibitors
650 0 4 _aReceptors, Interleukin-17
_xantagonists & inhibitors
650 0 4 _aTh17 Cells
_xdrug effects
700 1 _aKolls, Jay K
773 0 _tNature reviews. Drug discovery
_gvol. 11
_gno. 10
_gp. 763-76
856 4 0 _uhttps://doi.org/10.1038/nrd3794
_zAvailable from publisher's website
999 _c22146396
_d22146396